Related Experiment Videos
Clusterin: a protective mediator for ischemic cardiomyocytes?
P A J Krijnen1, S A G M Cillessen, R Manoe
1VU Univ. Medical Center, Dept. of Pathology, De Boelelaan 1117, 1007 MB Amsterdam, The Netherlands. paj.krijnen@vumc.nl
Summary
Clusterin protects heart cells from ischemic injury by upregulating independently of complement. This finding reveals a novel protective mechanism for cardiomyocytes during heart attacks.
Area of Science:
- Cardiovascular Research
- Cellular Biology
- Immunology
Background:
- Acute myocardial infarction involves complex cellular stress responses.
- The role of clusterin and complement activation in cardiac injury is not fully understood.
Purpose of the Study:
- To investigate the relationship between clusterin and complement in human myocardial infarction.
- To evaluate clusterin's protective effects on cardiomyocytes under ischemic conditions.
Main Methods:
- Immunohistochemical analysis of clusterin and complement factor C3d in human infarcted hearts.
- In vitro studies using H9c2 cardiomyoblasts and isolated adult rat cardiomyocytes subjected to ischemia.
- Flow cytometry to analyze clusterin binding to cells.
- Cell viability assays to assess clusterin's protective effects.
Main Results:
- Clusterin was found on viable cardiomyocytes in human infarcts, distinct from complement deposition.
- Ischemia induced rapid clusterin expression in H9c2 cells, decreasing upon reperfusion.
- Clusterin bound to stressed and dying H9c2 cells.
- Clusterin significantly inhibited ischemia-induced cell death in both cell types, independent of complement.
Conclusions:
- Ischemia upregulates clusterin in viable cardiomyocytes.
- Clusterin confers protection against ischemic cell death through a complement-independent pathway.
- Clusterin represents a potential therapeutic target for mitigating myocardial infarction damage.